Home › NDC Lookup › Ingredients › Prenatal With Ferrous Fumarate And Folic... › 39328-0106-10
⚪image loading
(from DailyMed)

Prenatal Plus Vitamins prenatal with ferrous fumarate and folic acid 924 ug; 276 ug; 120 mg; 10 ug; 10 mg; 1.84 mg; 3 mg; 20 mg; 10 mg Tablet, 100-count — NDC 39328-106-10 (Billing 39328-0106-10)

by Patrin Pharma, Inc. · 100 TABLET in 1 BOTTLE, PLASTIC

This is a package of 100 tablets of Prenatal Plus Vitamins prenatal with ferrous fumarate and folic acid 924 ug; 276 ug; 120 mg; 10 ug; 10 mg; 1.84 mg; 3 mg; 20 mg; 10 mg Tablet from Patrin Pharma, Inc., marketed since Apr 2013 and currently FDA-listed; retail pharmacies pay about $0.1126 per tablet (NADAC). It is this product's only package size.

NDC 39328-0106-10
🏷️ FDA NDC (as labeled) 39328-106-10 billing pads the product segment with a zero
Rx only On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 39328-106-10 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
39328 labeler · 106 product · 10 package
Package marketed since
Apr 1, 2013
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 3932810610 2
Medicaid fills, this package
209,725 prescriptions in the last four reported quarters
FDA record last changed
Oct 1, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 39328-106-10
Product NDC 39328-106
11-digit billing NDC 39328010610
NCPDP billing unit EA — each (per item)
UNII 3LE3D9D6OY, 01YAE03M7J, PQ6CK8PD0R, 1C6V77QF41, WR1WPI7EW8, 8K0I04919X +9 more
SPL Set ID 59c5c1a4-3f42-441a-b842-903f9bab346f
Established class (EPC) Vitamin C; Vitamin D; Vitamin B12
Chemical class Ascorbic Acid; Vitamin D; Vitamin B 12
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2013-04-01
Route ORAL
Dosage form TABLET
Substance VITAMIN A ACETATE; BETA CAROTENE; ASCORBIC ACID; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL ACETATE, DL-; THIAMINE MONONITRATE; RIBOFLAVIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; CYANOCOBALAMIN; CALCIUM CARBONATE; FERROUS FUMARATE; ZINC OXIDE; CUPRIC

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 78512015000324
GPI class Prenatal
GCN Seq No 066420
GCN 28688
HICL code 037025
Ingredient (HICL) Pnv,Calcium 72/Iron/Folic Acid
HIC1 code C
Therapeutic class — broad (HIC1) Electrolyte Balance/Metabolism/Nutrition
HIC2 code C6
Therapeutic class — intermediate (HIC2) Vitamins
HIC3 code C6F
Therapeutic class — specific (HIC3) Prenatal Vitamin Preparations
AHFS code 20:04.04.00
AHFS class Iron Preparations
FDB label name PRENATAL VITAMIN PLUS LOW IRON
FDB brand name Prenatal Vitamin Plus Low Iron
Legend status Q — Non-drug — dietary supplement, vitamin, medical food, or herbal preparation
Quick answers
  • GSN (GCN sequence number): 066420
  • GCN: 28688
  • GPI-14 (Medi-Span): 78512015000324
  • HICL (First Databank): 037025
  • AHFS class code: 20:04.04.00
Why two NDCs? The FDA registers this code as 39328-106-10 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 39328-0106-10. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name PRENATAL VITAMIN PLUS LOW IRON Ingredient Pnv,Calcium 72/Iron/Folic Acid
🧪 What is this product?

Prenatal Plus Vitamins is an oral tablet containing a combination of vitamins and minerals typically used during pregnancy. The product includes vitamins A, C, D, and E along with B vitamins (thiamine, riboflavin, niacinamide, B6, B12, and folic acid), which are commonly included in prenatal formulations to support maternal and fetal nutrition. It also contains ferrous fumarate (an iron source), calcium, zinc, and copper, minerals typically found in prenatal supplements. This product is marketed without an approved FDA application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.113 $11.26 / 100 tablets
Medicaid paysCMS SDUD · 12 mo $0.2236 $22.36 / 100 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.127 $0.101
Flat over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
39328-0106-10 You're viewing this Main listing 100 TABLET in 1 BOTTLE, PLASTIC 2013-04-01 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Prenatal Plus Vitamins 924 ug/1; 276 ug/1; 120 mg/1; 10 ug/1; 10 mg/1; 1.84 mg/1; 3 mg/1; 20 mg/1; 10 mgthis 39328-0106-10 Patrin 100 tablets $0.113 — Availability likely —
Prenatal Plus Vitamins 924 ug/1; 276 ug/1; 120 mg/1; 10 ug/1; 10 mg/1; 1.84 mg/1; 3 mg/1; 20 mg/1; 10 mg 70518-4258-00 REMEDYREPACK 100 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2013
On the market since
Apr 2013
📍
2026
Currently FDA-listed
13 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII L06K8R7DQK
    A synthetic blue dye approved by the FDA for use in medications and foods. It serves as a colorant to make pills and liquids visually distinct and easier to identify.
  • UNII WZB9127XOA
    A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
  • UNII H77VEI93A8
    A synthetic yellow dye used to color medications. It helps identify the drug and make it visually distinctive, with no effect on how the medicine works.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 7CVR7L4A2D
    A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII B697894SGQ
    Polyethylene glycol 400 is a clear, thick liquid made from petroleum-derived polymers. It acts as a solvent and humectant in medicines, helping dissolve active ingredients and retain moisture in the formulation.
  • UNII 4ELV7Z65AP
    Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

10 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerPatrin Pharma, Inc.
Labeler code39328
First marketedApr 2013
Product typeHuman Prescription Drug
Portfolio18 products on file

More NDCs from Patrin Pharma, Inc. labeler code 39328

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🚨 Boxed Warning ⏱️ Dosage and Administration 📦 Storage and Handling 📋 Description ⚠️ Precautions 📄 Package Label / Principal Display Panel
🚨 Boxed Warning 39 words ▾

WARNING Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six. Keep this product out of the reach of children. In case of accidental overdose, call a Physician or Poison Control Center immediately.

⏱️ Dosage and Administration 20 words ▾

Directions Use before, during and after pregnancy under the supervision of a medical professional. One tablet daily or as prescribed.

📦 Storage and Handling 25 words ▾

Storage Store at room temperature, USP. Protect from light and moisture. Dispense in a tight, light-resistant container. Contact with moisture may discolor or erode tablets.

📋 Description 161 words ▾

Supplement Facts Serving Size: 1 Tablet Amount per Serving % Daily Value Daily Value is for Pregnant and Lactating Women Vitamin A 1200 mcg 92% (Acetate and Beta Carotene) RAE Vitamin C (Ascorbic Acid) 120 mg 100% Vitamin D-3 (Cholecalciferol) 10 mcg 67% Vitamin E (dl-α Tocopheryl Acetate) 10 mg 53% Vitamin B-1 (Thiamine Mononitrate) 1.84 mg 131% Vitamin B-2 (Riboflavin) 3 mg 188% Niacin (Niacinamide) 20 mg 111% Vitamin B-6 (Pyridoxine HCl) 10 mg 500% Folic Acid 1667 mcg 278% DFE (1 mg) Vitamin B-12 (Cyanocobalamin) 12 mcg 429% Calcium (Calcium Carbonate) 200 mg 15% Iron (Ferrous Fumarate) 27 mg 100% Zinc (Zinc Oxide) 25 mg 192% Copper(Cupric Oxide) 2 mg 154% Other Ingredients: Hypromellose, Magnesium Stearate, Maltodextrin, Microcrystalline Cellulose, Polyethylene Glycol, Stearic Acid, Titanium Dioxide, FD&C Blue #2 lake, FD&C Red #40 lake, FD&C Yellow #6 lake

Description Prenatal Plus Vitamins is a prescription folic acid containing dietary vitamin and mineral supplement for women before, during and after pregnancy.

⚠️ Precautions 23 words ▾

Caution Folic acid may partially correct the hematological damage due to Vitamin B-12 deficiency of pernicious anemia while the associated neurological damage progresses.

📄 Package Label / Principal Display Panel 43 words ▾

PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label Rx Only NDC 39328-106-10 Prenatal Plus Vitamins 27 mg Fe & 1 mg FA Before, During and After Pregnancy 100 tablets Made in the USA PATRIN PHARMA PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
209.7K
Units reimbursed last 4 qtrs
8.8M
Gross reimbursed last 4 qtrs
$1.97M
Avg / prescription
$9.40
Avg / unit
$0.2236
Latest quarter Q1 2026
49.1KRx
Medicaid pays / ea
$0.2236
gross reimbursed
vs
NADAC / ea
$0.1126
acquisition cost
=
Spread
+$0.1110
+99% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
40% FFS 60% MCO
Fee-for-service · 83,838 Rx Managed care · 125,887 Rx
State Medicaid map
Alaska: 5,075 units · 692 per 100k residents AK Maine: 75,199 units · 5,391 per 100k residents ME Washington: 346,578 units · 4,436 per 100k residents WA Idaho: 68,552 units · 3,490 per 100k residents ID Montana: 43,175 units · 3,814 per 100k residents MT North Dakota: 27,398 units · 3,499 per 100k residents ND Minnesota: 293,395 units · 5,114 per 100k residents MN Wisconsin: 301,227 units · 5,097 per 100k residents WI Michigan: 841,296 units · 8,382 per 100k residents MI New York: 2,284,369 units · 11,672 per 100k residents NY Vermont: 15,010 units · 2,320 per 100k residents VT New Hampshire: 5,010 units · 357 per 100k residents NH Oregon: 183,569 units · 4,337 per 100k residents OR Nevada: 16,476 units · 516 per 100k residents NV Wyoming: 7,528 units · 1,289 per 100k residents WY South Dakota: 19,539 units · 2,126 per 100k residents SD Iowa: 79,953 units · 2,493 per 100k residents IA Illinois: 144,861 units · 1,154 per 100k residents IL Indiana: 108,386 units · 1,580 per 100k residents IN Ohio: 570,861 units · 4,844 per 100k residents OH Pennsylvania: 598,207 units · 4,615 per 100k residents PA New Jersey: 212,962 units · 2,292 per 100k residents NJ Massachusetts: 168,808 units · 2,411 per 100k residents MA California: 4,922 units · 12.6 per 100k residents CA Utah: 53,181 units · 1,556 per 100k residents UT Colorado: 167,433 units · 2,848 per 100k residents CO Nebraska: 50,395 units · 2,548 per 100k residents NE Missouri: 433,711 units · 7,000 per 100k residents MO Kentucky: 204,388 units · 4,516 per 100k residents KY West Virginia: 41,617 units · 2,351 per 100k residents WV Virginia: 11,687 units · 134 per 100k residents VA Maryland: 114,912 units · 1,859 per 100k residents MD Connecticut: 26,442 units · 731 per 100k residents CT Rhode Island: 840 units · 76.7 per 100k residents RI Arizona: 150,879 units · 2,030 per 100k residents AZ New Mexico: 82,156 units · 3,886 per 100k residents NM Kansas: 13,605 units · 463 per 100k residents KS Arkansas: 65,000 units · 2,119 per 100k residents AR Tennessee: no data reported TN North Carolina: 198,392 units · 1,831 per 100k residents NC South Carolina: 27,295 units · 508 per 100k residents SC Delaware: 9,936 units · 964 per 100k residents DE Oklahoma: 101,286 units · 2,499 per 100k residents OK Louisiana: 96,043 units · 2,100 per 100k residents LA Mississippi: 41,707 units · 1,419 per 100k residents MS Alabama: 22,355 units · 438 per 100k residents AL Georgia: 94,682 units · 858 per 100k residents GA D.C.: 36,998 units · 5,449 per 100k residents DC Hawaii: no data reported HI Texas: 87,911 units · 288 per 100k residents TX Florida: 133,337 units · 590 per 100k residents FL
Units reimbursed · per 100k residents
12.611,672
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 11,672 /100k
2 Michigan 8,382 /100k
3 Missouri 7,000 /100k
4 D.C. 5,449 /100k
5 Maine 5,391 /100k
6 Minnesota 5,114 /100k
7 Wisconsin 5,097 /100k
8 Ohio 4,844 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Prenatal Plus Vitamins (this brand).

Top reported reactions

Organ Transplant1
Pancreas Transplant Rejection1
Pruritus Generalised1
Rash Papular1

Reporter sex

0 reports
Female · 100%

Serious outcomes

Hospitalization1
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Finished prescription product Marketed without an FDA application

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) ✓ Available
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Patrin Pharma, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Patrin Pharma, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 39328-0090-16 · Patrin 39328-0120-50 · Patrin →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.